GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Oncologix Tech Inc (OTCPK:OCLG) » Definitions » Enterprise Value

Oncologix Tech (Oncologix Tech) Enterprise Value : $0.33 Mil (As of May. 05, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Oncologix Tech Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Oncologix Tech's Enterprise Value is $0.33 Mil. Oncologix Tech's EBIT for the trailing twelve months (TTM) ended in May. 2015 was $-0.61 Mil. Therefore, Oncologix Tech's EV-to-EBIT ratio for today is -0.54.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Oncologix Tech's Enterprise Value is $0.33 Mil. Oncologix Tech's EBITDA for the trailing twelve months (TTM) ended in May. 2015 was $-0.59 Mil. Therefore, Oncologix Tech's EV-to-EBITDA ratio for today is -0.56.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Oncologix Tech's Enterprise Value is $0.33 Mil. Oncologix Tech's Revenue for the trailing twelve months (TTM) ended in May. 2015 was $4.61 Mil. Therefore, Oncologix Tech's EV-to-Revenue ratio for today is 0.07.


Oncologix Tech Enterprise Value Historical Data

The historical data trend for Oncologix Tech's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncologix Tech Enterprise Value Chart

Oncologix Tech Annual Data
Trend Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12 Aug13
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.70 4.62 4.22 2.08 2.15

Oncologix Tech Quarterly Data
Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.41 2.70 3.60 4.77 -

Competitive Comparison of Oncologix Tech's Enterprise Value

For the Shell Companies subindustry, Oncologix Tech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncologix Tech's Enterprise Value Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Oncologix Tech's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Oncologix Tech's Enterprise Value falls into.



Oncologix Tech Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Oncologix Tech's Enterprise Value for the fiscal year that ended in Aug. 2013 is calculated as

Oncologix Tech's Enterprise Value for the quarter that ended in May. 2015 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncologix Tech  (OTCPK:OCLG) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Oncologix Tech's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.332/-0.61
=-0.54

Oncologix Tech's current Enterprise Value is $0.33 Mil.
Oncologix Tech's EBIT for the trailing twelve months (TTM) ended in May. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.61 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Oncologix Tech's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=0.332/-0.591
=-0.56

Oncologix Tech's current Enterprise Value is $0.33 Mil.
Oncologix Tech's EBITDA for the trailing twelve months (TTM) ended in May. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.59 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Oncologix Tech's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.332/4.607
=0.07

Oncologix Tech's current Enterprise Value is $0.33 Mil.
Oncologix Tech's Revenue for the trailing twelve months (TTM) ended in May. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncologix Tech Enterprise Value Related Terms

Thank you for viewing the detailed overview of Oncologix Tech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncologix Tech (Oncologix Tech) Business Description

Traded in Other Exchanges
N/A
Address
370 Amapola Avenue, Suite 200-A, Torrance, CA, USA, 90501
Oncologix Tech Inc is a Shell company. the company currently doesn't have any specific business and is looking forward to acquiring other companies.
Executives
Anthony Silverman director, officer: CEO and President 7625 E. VIA DEL REPOSA, SCOTTSDALE AZ 85258
Stanley Schloz other: Director, Resigned 12-27-07

Oncologix Tech (Oncologix Tech) Headlines

No Headlines